Sabra Health Care REIT (NASDAQ:SBRA) Releases FY 2025 Earnings Guidance

Sabra Health Care REIT (NASDAQ:SBRA) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.430-1.460 for the period, compared to the consensus estimate of 1.480. The company issued revenue guidance of -.

Sabra Health Care REIT Price Performance

Sabra Health Care REIT stock traded up $0.07 during trading hours on Thursday, hitting $16.62. 756,932 shares of the stock were exchanged, compared to its average volume of 1,988,769. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. The stock has a market capitalization of $3.93 billion, a P/E ratio of 40.40, a P/E/G ratio of 1.98 and a beta of 1.25. Sabra Health Care REIT has a 12 month low of $13.31 and a 12 month high of $20.03. The business’s 50-day moving average is $16.90 and its two-hundred day moving average is $17.63.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The business had revenue of $182.35 million for the quarter, compared to analysts’ expectations of $178.01 million. Equities research analysts expect that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 7.22%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 292.68%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on SBRA. Mizuho reissued a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Tuesday, January 7th. Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their price objective for the company from $18.00 to $17.00 in a research note on Friday, January 17th. Finally, Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.